Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation

S Nattel, A Maguy, S Le Bouter… - Physiological …, 2007 - journals.physiology.org
Rhythmic and effective cardiac contraction depends on appropriately timed generation and
spread of cardiac electrical activity. The basic cellular unit of such activity is the action …

Cellular basis of triggered arrhythmias in heart failure

SM Pogwizd, DM Bers - Trends in cardiovascular medicine, 2004 - Elsevier
Ventricular tachycardia in nonischemic heart failure (HF) initiates by a nonreentrant
mechanism that appears to be due to triggered activity primarily from delayed …

Functional role of inward rectifier current in heart probed by Kir2. 1 overexpression and dominant-negative suppression

J Miake, E Marbán, HB Nuss - The Journal of clinical …, 2003 - Am Soc Clin Investig
The inward rectifier current I K1 is tightly regulated regionally within the heart,
downregulated in heart failure, and genetically suppressed in Andersen syndrome. We used …

Innovative approaches to anti-arrhythmic drug therapy

S Nattel, L Carlsson - Nature reviews Drug discovery, 2006 - nature.com
Normal cardiac function requires an appropriate and regular beating rate (cardiac rhythm).
When the heart rhythm is too fast or too slow, cardiac function can be impaired, with …

Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles

GR Li, CP Lau, TK Leung, S Nattel - Heart rhythm, 2004 - Elsevier
OBJECTIVES: This study was designed to determine whether ionic currents in right
ventricular myocytes from explanted human transplant recipient hearts are related to right …

Novel therapeutic approaches for heart failure by normalizing calcium cycling

XHT Wehrens, AR Marks - Nature Reviews Drug Discovery, 2004 - nature.com
Congestive heart failure is the leading cause of death in the Western world. Abnormal
intracellular calcium (Ca2+) handling is central to the pathogenesis of heart failure because …

Biological therapies for cardiac arrhythmias: can genes and cells replace drugs and devices?

HC Cho, E Marbán - Circulation research, 2010 - Am Heart Assoc
Cardiac rhythm disorders reflect failures of impulse generation and/or conduction. With the
exception of ablation methods that yield selective endocardial destruction, present therapies …

Andersen‐Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity

M Donaldson, G Yoon, YH Fu, L Ptacek - Annals of medicine, 2004 - Taylor & Francis
Due to its varied and variable phenotypes, Andersen‐Tawil syndrome (ATS) holds a unique
place in the field of channelopathies. Patients with ATS typically present with the triad of …

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis

J Li, C Xu, Y Liu, Y Li, S Du, R Zhang, Y Sun… - Basic Research in …, 2020 - Springer
Ventricular arrhythmia is the most common cause of sudden cardiac death in patients with
myocardial infarction (MI). Fibroblast growth factor 21 (FGF21) has been shown to play an …

Phospholamban as a Crucial Determinant of the Inotropic Response of Human Pluripotent Stem Cell–Derived Ventricular Cardiomyocytes and Engineered 3 …

G Chen, S Li, I Karakikes, L Ren… - Circulation …, 2015 - Am Heart Assoc
Background—Human (h) embryonic stem cells (ESCs) and induced pluripotent stem cells
(iPSCs) serve as a potential unlimited ex vivo source of cardiomyocytes (CMs). However, a …